NCT04716010 2023-08-18Developing and Evaluating Product MessagingUniversity of North Carolina, Chapel HillPhase NA Completed4,160 enrolled 26 charts
NCT00499291 2023-05-25Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid TumorsEastern Cooperative Oncology GroupPhase NA Withdrawn
NCT04443036 2020-06-23Clinical Study of Nab-paclitaxel Combined With Toripalimab in Local Advanced or Metastatic G/GEJ CarcinomaChina Medical University, ChinaPhase NA Unknown44 enrolled